ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 742,09
2,33%
Dow Jones
42 154,04
0,57%
DAX
19 238,36
1,67%
Brent Oil
70,90
-3,13%
Bitcoin
65 272,79
3,39%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Anika Therapeutics Inc (ANIK)

  7. Anika Therapeutics Inc (ANIK) Actualités

ANIK

Anika Therapeutics (ANIK)

Anika Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ANIK
DateHeureSourceTitreSymboleSociété
09/09/202422h45GlobeNewswire Inc.Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ANIKAnika Therapeutics Inc
08/08/202423h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ANIKAnika Therapeutics Inc
08/08/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ANIKAnika Therapeutics Inc
08/08/202422h05GlobeNewswire Inc.Anika Reports Second Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
05/08/202422h01GlobeNewswire Inc.Anika to Participate in the Sidoti Virtual Investor ConferenceNASDAQ:ANIKAnika Therapeutics Inc
25/07/202415h00GlobeNewswire Inc.Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 2024NASDAQ:ANIKAnika Therapeutics Inc
11/07/202422h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
11/07/202414h30GlobeNewswire Inc.Anika Announces Full Market Release of the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Scaffold for Rotator Cuff and Other Tendon RepairsNASDAQ:ANIKAnika Therapeutics Inc
11/06/202423h07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ANIKAnika Therapeutics Inc
11/06/202423h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ANIKAnika Therapeutics Inc
05/06/202422h07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:ANIKAnika Therapeutics Inc
30/05/202422h31Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
28/05/202422h05GlobeNewswire Inc.Anika Enters into Cooperation Agreement with Caligan PartnersNASDAQ:ANIKAnika Therapeutics Inc
08/05/202422h08GlobeNewswire Inc.Anika Announces CFO TransitionNASDAQ:ANIKAnika Therapeutics Inc
08/05/202422h05GlobeNewswire Inc.Anika Reports First Quarter 2024 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
18/04/202422h01GlobeNewswire Inc.Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024NASDAQ:ANIKAnika Therapeutics Inc
02/04/202414h00GlobeNewswire Inc.Anika to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:ANIKAnika Therapeutics Inc
13/03/202421h05GlobeNewswire Inc.Anika Reports Fourth Quarter and Year-End 2023 Financial ResultsNASDAQ:ANIKAnika Therapeutics Inc
13/03/202412h03IH Market NewsMixed Futures Amidst Quiet Economic Schedule; Oil Prices ClimbNASDAQ:ANIKAnika Therapeutics Inc
27/02/202422h01GlobeNewswire Inc.Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024NASDAQ:ANIKAnika Therapeutics Inc
13/02/202415h00GlobeNewswire Inc.Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual MeetingNASDAQ:ANIKAnika Therapeutics Inc
09/02/202417h09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
22/01/202415h29Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:ANIKAnika Therapeutics Inc
19/01/202422h52Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ANIKAnika Therapeutics Inc
12/01/202422h35Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:ANIKAnika Therapeutics Inc
28/11/202315h00GlobeNewswire Inc.Anika Announces First Surgeries Performed using the Integrity™ Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market ReleaseNASDAQ:ANIKAnika Therapeutics Inc
07/11/202322h05GlobeNewswire Inc.Anika to Participate in Upcoming Investor ConferencesNASDAQ:ANIKAnika Therapeutics Inc
02/11/202321h05GlobeNewswire Inc.Anika Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance on Growing Momentum Across the BusinessNASDAQ:ANIKAnika Therapeutics Inc
10/10/202315h00GlobeNewswire Inc.Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023NASDAQ:ANIKAnika Therapeutics Inc
19/09/202315h00GlobeNewswire Inc.Anika Announces the Full Market Release of the RevoMotion™ Reverse Shoulder Arthroplasty System during the 2023 Orthopaedic Summit: Evolving Technologies (OSET) Annual MeetingNASDAQ:ANIKAnika Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ANIK

Dernières Valeurs Consultées

EU
RNO
Renault
COIN
SOLUSD
Solana
EU
GLE
Societe Generale
EU
BN
Danone
EU
VK
Vallourec
EU
ML
Michelin
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
KO
Coca Cola
EU
DG
Vinci
EU
VIV
Vivendi
COIN
ADAUSD
Cardano
EU
RI
Pernod Ricard
NASDAQ
NVDA
NVIDIA
COIN
AVAXUSD
Avalanche
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés